Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Sara L Gale
Comparative Effectiveness of Tocilizumab Versus TNF Inhibitors as Monotherapy or in Combination With Conventional Synthetic Disease-Modifying Antirheumatic Drugs in Patients With Rheumatoid Arthritis After the Use of at Least One Biologic Disease-Modifying Antirheumatic Drug: Analyses From the Pan-European TOCERRA Register Collaboration
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Polycyclic Aromatic Hydrocarbon Exposure and Wheeze in a Cohort of Children With Asthma in Fresno, CA
Journal of Exposure Science and Environmental Epidemiology
Epidemiology
Public Health
Environmental
Toxicology
Pollution
Occupational Health
Related publications
Lipid Profiles in Rheumatoid Arthritis Patients Treated With Disease-Modifying Antirheumatic Drugs
Reumatologia
Rheumatology
Allergy
Immunology
Safety of Abatacept Compared With Other Biologic and Conventional Synthetic Disease-Modifying Antirheumatic Drugs in Patients With Rheumatoid Arthritis: Data From an Observational Study
Arthritis Research & Therapy
SAT0206 Retention of Tocilizumab as Monotherapy Versus TNF Inhibitors With Conventional Synthetic Dmards in Rheumatoid Arthritis Patients With Inadequate Response to TNF Inhibitors: A Study From the Tocerra Collaboration
Assessing the Effectiveness of Synthetic and Biologic Disease-Modifying Antirheumatic Drugs in Psoriatic Arthritis &Ndash; A Systematic Review
Psoriasis: Targets and Therapy
Dermatology
Rheumatology
FRI0754-HPR Impact of Corticosteroid Utilization on Biologic Disease-Modifying Antirheumatic Drug Initiation Among Patients With Rheumatoid Arthritis
Predictors of Stopping and Starting Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis
Arthritis Care and Research
Rheumatology
Step-Up Combination Versus Switching of Non-Biological Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis: Results From a Retrospective Observational Study
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Changes in Use of Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis in the United States During 1983-2009
Arthritis Care and Research
Rheumatology
Real-World Effectiveness of Biologic Disease-Modifying Antirheumatic Drugs for the Treatment of Rheumatoid Arthritis After Etanercept Discontinuation in the United Kingdom, France, and Germany
Clinical Therapeutics
Pharmacology
